Form 4: Vicarious Surgical President Sells Shares for Tax Obligations

Vicarious Surgical Inc.'s President, Adam David Sachs, sold 816 shares of Class A Common Stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Adam David Sachs, President, Director, and 10% Owner of Vicarious Surgical Inc. (RBOT), sold 816 shares of Class A Common Stock.
• The transaction occurred on November 20, 2025, at a weighted average price of $2.715 per share.
• The sale was a "sell to cover" transaction, mandated by the company's equity incentive plan, to satisfy tax withholding obligations from the vesting of restricted stock units granted on May 19, 2022.
• Following the transaction, Mr. Sachs directly beneficially owns 48,348 shares of Class A Common Stock.
• The sales price ranged from $2.54 to $2.94 per share.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary 'sell to cover' for tax obligations related to RSU vesting, which is a neutral event for company sentiment.

Positives

• The transaction is part of a routine equity incentive plan, indicating ongoing employee compensation and retention mechanisms.
• The sale was non-discretionary, solely for tax purposes, not signaling a lack of confidence in the company.

Negatives

• A reduction in direct beneficial ownership by a key insider, even if for tax purposes.

Future Outlook

NA

Management Comments

• The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.
• The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

This is a routine insider transaction common across all industries for executives receiving equity compensation. It does not provide specific industry context for Vicarious Surgical beyond the fact that they use equity incentive plans.

Comparison to Industry Standards

• "Sell to cover" transactions are a standard and common mechanism for executives in publicly traded companies across various industries to manage tax liabilities arising from the vesting of equity awards like Restricted Stock Units (RSUs). This practice is widely adopted by companies to facilitate tax compliance for their employees and executives.

Stakeholder Impact

• Shareholders: Minimal impact, as it's a small, non-discretionary sale for tax purposes, not indicative of a change in insider confidence.
• Employees: Reflects the ongoing operation of the company's equity incentive plan, which is a positive for employee retention and motivation.

Key Dates

Recommendation

This Form 4 details a routine, non-discretionary "sell to cover" transaction by an insider to satisfy tax obligations from RSU vesting. Such a transaction does not reflect a change in the insider's confidence in the company's future prospects and is a common occurrence in equity compensation plans. Therefore, it provides no new fundamental information that would warrant a change in investment recommendation. Investors should continue to hold based on their existing analysis of Vicarious Surgical's fundamentals.

Keywords

Vicarious Surgical, RBOT, Adam David Sachs, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Equity Incentive Plan, Sell to Cover, Tax Withholding